Full year 2023 total revenue was $36.7 million, down 11% year-over-yearAchieved 36% annual growth in the number of Clinical Solutions customers in 2023Company provides 2024 revenue guidance of $35-38 million HOLLISTER,
Evolent Health (NYSE:EVH – Free Report) had its target price trimmed by Canaccord Genuity Group from $47.00 to $45.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the technology company’s stock. A number of other equities analysts also recently weighed in on EVH. […]
Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]